Stay updated on Durvalumab Combinations in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Combinations in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Combinations in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to related updates and FAQs.
    Difference
    0.5%
    Check dated 2026-10-24T22:22:07.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The website footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-17T22:25:06.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now identifies the site as revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-10T22:16:15.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision: v3.7.0 added to the page history, replacing v3.6.6. This appears to be a software update to the site UI and layout rather than a change to study details.
    Difference
    0.1%
    Check dated 2026-09-19T20:32:44.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The revision history now shows the latest revision as v3.6.6, replacing the previous v3.6.5 entry.
    Difference
    0.1%
    Check dated 2026-08-29T19:14:12.000Z thumbnail image
  6. Check
    81 days ago
    Change Detected
    Summary
    A new revision (v3.6.5) has been added to the study's record history, replacing the previous revision (v3.6.4). This reflects an update to the page's revision metadata without impacting the study data or status.
    Difference
    0.1%
    Check dated 2026-08-08T23:33:17.000Z thumbnail image

Stay in the know with updates to Durvalumab Combinations in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Combinations in NSCLC Clinical Trial page.